A microvascularized in vitro liver model for disease modeling and drug discovery
Preprint
Abstract
Drug discovery for complex liver diseases faces alarming attrition rates. The lack of non-clinical models that recapitulate key aspects of liver (patho)-physiology is likely contributing to the inefficiency of developing effective treatments. Of particular notice is the common omission of an organized microvascular component despite its importance in maintaining liver function and its involvement in the development of several pathologies. Increasing the complexity of in vitro models is usually associated with a lack of scalability and robustness which hinders their implementation in drug development pipelines. Here, we describe a comprehensive liver MPS model comprising stellates, liver-derived endothelial cells and hepatocytes conceived within a scalable and automated platform. We show that endothelial cells self-organize in a microvascular network when co-cultured with stellates in a hydrogel. In a tri-culture, hepatocytes polarize accordingly, with a basolateral side facing blood vessels and an apical side facing bile-canaliculi-like structures. Stellates interact and surround the hollow microvessels. Steatosis was induced by exogenous administration of fatty acids which could be prevented by co-administration of firsocostat. Administration of TGF-β resulted in an activated stellate cells phenotype which could be prevented by the co-administration of SB-431542. The model was implemented on a microtiter plate format comprising 64 chips which enabled the development of a fully automated, multiplexed fibrosis assay with a robust Z’ factor suitable for high-throughput applications.Keywords
This publication has 60 references indexed in Scilit:
- In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bedAngiogenesis, 2022
- Journey of organ on a chip technology and its role in future healthcare scenarioApplied Surface Science Advances, 2022
- Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosisAdvanced Drug Delivery Reviews, 2021
- Bioengineered Multicellular Liver Microtissues for Modeling Advanced Hepatic Fibrosis Driven Through Non‐Alcoholic Fatty Liver DiseaseSmall, 2021
- Functionality of primary hepatic non-parenchymal cells in a 3D spheroid model and contribution to acetaminophen hepatotoxicityArchives of Toxicology, 2020
- Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver diseaseCellular and Molecular Life Sciences, 2018
- Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injuryArchives of Toxicology, 2017
- Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human LiverCell, 2015
- Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanismsAngiogenesis, 2010
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007